Xerava Unione Europea - italiano - EMA (European Medicines Agency)

xerava

paion deutschland gmbh - eravacycline - infection; bacterial infections - antibatterici per uso sistemico, - xerava è indicato per il trattamento di complicate intra-addominali infezioni (ciai) negli adulti. dovrebbero essere prese in considerazione le linee guida ufficiali sull'uso appropriato degli agenti antibatterici..

ROSUVASTATINA E EZETIMIBE MYLAN Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

rosuvastatina e ezetimibe mylan

mylan ire healthcare limited - rosuvastatina e ezetimibe - rosuvastatina e ezetimibe

Giapreza Unione Europea - italiano - EMA (European Medicines Agency)

giapreza

paion deutschland gmbh - l'angiotensina ii acetato - hypotension; shock - agenti che agiscono sul sistema renina-angiotensina - giapreza è indicato per il trattamento dell'ipotensione refrattaria in pazienti adulti con settico o altri distributiva shock che rimangono ipotensivo, nonostante l'adeguato volume di restituzione e di applicazione di catecolamine e di altre terapie vasoattive.

Azacitidine Mylan Unione Europea - italiano - EMA (European Medicines Agency)

azacitidine mylan

mylan ireland limited - azacitidina - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - agenti antineoplastici - azacitidine mylan is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with:intermediate 2 and high risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 29% marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 30% blasts and multi lineage dysplasia, according to world health organisation (who) classification,aml with > 30% marrow blasts according to the who classification.

Byfavo Unione Europea - italiano - EMA (European Medicines Agency)

byfavo

paion deutschland gmbh - remimazolam besilate - sedazione cosciente - psicolettici - remimazolam is indicated in adults for procedural sedation. remimazolam 50 mg is indicated in adults for intravenous induction and maintenance of general anaesthesia.

Abiraterone Mylan Unione Europea - italiano - EMA (European Medicines Agency)

abiraterone mylan

mylan ireland limited - abiraterone acetato - neoplasie prostatiche - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Sugammadex Mylan Unione Europea - italiano - EMA (European Medicines Agency)

sugammadex mylan

mylan ireland limited - sugammadex sodium - blocco neuromuscolare - tutti gli altri prodotti terapeutici - reversal of neuromuscular blockade induced by   rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.